InMode Participates in Multiple Investor Conferences
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 13 2026
0mins
Source: PRnewswire
- Investor Conference Schedule: InMode will participate in the Barclays Virtual West Coast Bus Tour on May 20, featuring outgoing CFO Yair Malca and Senior VP of Finance Moshik Itzkovich, aimed at enhancing investor engagement.
- Healthcare Industry Conference: On June 3, InMode will also attend the Jefferies Global Healthcare Conference for an in-person fireside chat, further showcasing its innovative capabilities in medical technology and increasing its visibility among investors.
- Technology Innovation Showcase: InMode focuses on developing and manufacturing medical devices utilizing novel radiofrequency technology across various fields, including plastic surgery and gynecology, aiming to drive industry advancement through emerging surgical procedures and improved existing treatments.
- Forward-Looking Statements: The company notes in its press release that future financial or operational performance may be influenced by various uncertainties, and actual results could differ materially from expectations, urging investors to exercise caution regarding these forward-looking statements.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy INMD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on INMD
Wall Street analysts forecast INMD stock price to rise
5 Analyst Rating
1 Buy
4 Hold
0 Sell
Hold
Current: 14.050
Low
15.00
Averages
17.33
High
21.00
Current: 14.050
Low
15.00
Averages
17.33
High
21.00
About INMD
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
InMode Appoints New CFO and Chairman
- Executive Appointments: InMode Ltd. announced the appointment of Moshik Itzkovich as Chief Financial Officer, succeeding Yair Malca who stepped down earlier this month; Itzkovich, previously the Senior Vice President of Finance, is expected to enhance the company's financial strategy with his extensive experience.
- Board Leadership Change: Shlomo Nass has been appointed as Chairman, succeeding Michael Anghel who retired earlier this month, and Nass's leadership is anticipated to provide new strategic direction and strengthen the board's governance capabilities.
- Market Reaction: Following the announcement, InMode's shares rose 0.07% in pre-market trading on Nasdaq, reaching $13.98 per share, indicating market confidence in the new executive team.
- Company Outlook: This executive transition reflects InMode's commitment to improving financial management and corporate governance, which may positively impact future business development and competitive positioning in the market.
See More
InMode Appoints New Chairman and CFO
- Board Leadership Change: InMode has appointed Dr. Shlomo Nass as the new Chairman of the Board, succeeding Dr. Michael Anghel, who retired earlier this month; Nass will leverage his extensive experience in corporate governance and financial oversight to drive the company's long-term strategic growth.
- Financial Leadership Transition: Moshik Itzkovich has been appointed as Chief Financial Officer, replacing Yair Malca, who stepped down earlier this month; Itzkovich's years in senior finance roles at InMode ensure continuity and stability in financial management.
- Support for Strategic Goals: CEO Moshe Mizrahy emphasized that Nass's expertise will be crucial for executing strategic priorities and enhancing shareholder value, indicating the company's commitment to governance and financial transparency.
- Transition Period Assurance: Yair Malca will serve as a consultant until the company's Annual General Meeting to ensure a smooth transition for the new CFO, reflecting the company's emphasis on leadership stability.
See More
InMode Appoints New Chairman and CFO to Drive Strategic Growth
- Board Appointment: InMode Ltd. has appointed Dr. Shlomo Nass as Chairman of the Board, succeeding the recently retired Dr. Michael Anghel, with Nass expected to leverage his extensive experience in corporate governance and financial oversight to support the company's long-term strategic growth.
- CFO Transition: Concurrently, Moshik Itzkovich has been appointed as Chief Financial Officer, replacing Yair Malca, with Itzkovich's long tenure in senior finance roles at InMode ensuring continuity and stability in financial management.
- Strategic Support: CEO Moshe Mizrahy emphasized that Nass's expertise will be crucial for executing strategic priorities and enhancing shareholder value, reflecting the company's commitment to future growth.
- Transition Assurance: Yair Malca will serve as a consultant until the company's Annual General Meeting to ensure a smooth transition for the new CFO, demonstrating the company's focus on leadership changes and commitment to future financial stability.
See More
InMode Participates in Multiple Investor Conferences
- Investor Conference Schedule: InMode will participate in the Barclays Virtual West Coast Bus Tour on May 20, featuring outgoing CFO Yair Malca and Senior VP of Finance Moshik Itzkovich, aimed at enhancing investor engagement.
- Healthcare Industry Conference: On June 3, InMode will also attend the Jefferies Global Healthcare Conference for an in-person fireside chat, further showcasing its innovative capabilities in medical technology and increasing its visibility among investors.
- Technology Innovation Showcase: InMode focuses on developing and manufacturing medical devices utilizing novel radiofrequency technology across various fields, including plastic surgery and gynecology, aiming to drive industry advancement through emerging surgical procedures and improved existing treatments.
- Forward-Looking Statements: The company notes in its press release that future financial or operational performance may be influenced by various uncertainties, and actual results could differ materially from expectations, urging investors to exercise caution regarding these forward-looking statements.
See More
InMode Announces Participation in Investor Conferences
- Investor Conference Schedule: InMode Ltd. will participate in the Barclays Virtual West Coast Bus Tour on May 20, 2026, featuring outgoing CFO Yair Malca and Senior VP of Finance Moshik Itzkovich, showcasing the company's innovations in medical technology.
- Face-to-Face Engagement: At the Jefferies Global Healthcare Conference on June 3, InMode will hold an in-person fireside chat at 12:45 PM ET in New York, providing one-on-one meetings with analysts to bolster investor confidence in the company's future prospects.
- Technological Innovation Background: InMode is a leading global provider of medical technologies focused on developing and manufacturing devices that utilize novel radiofrequency technology, committed to advancing emerging surgical procedures and improving existing treatments, highlighting its technical prowess in the healthcare sector.
- Forward-Looking Statement Reminder: The company notes that all forward-looking statements are based on management's current expectations and assumptions, with actual outcomes potentially differing significantly due to uncertainties and risks, urging investors to approach these statements with caution.
See More
InMode Reports Q1 2026 Financial Results with Mixed Performance
- Revenue Growth: InMode's Q1 2026 GAAP revenues reached $82 million, reflecting a 5% year-over-year increase, indicating the company's ability to maintain stable growth even in a challenging macroeconomic environment, which enhances market confidence.
- Margin Decline: Despite the revenue increase, GAAP gross margin fell from 78% in 2025 to 75% in Q1 2026, primarily due to rising costs, which could impact future profitability and investor sentiment.
- Shareholder Returns: As of March 31, 2026, InMode repurchased 2.55 million ordinary shares, returning $34.8 million to shareholders, demonstrating a proactive approach to capital allocation that helps enhance shareholder value.
- Executive Changes: CFO Yair Malca has stepped down and will serve as a consultant, while Board Chair Dr. Michael Anghel has resigned, indicating potential shifts in the company's strategic direction and market response.
See More
InMode Appoints New CFO and Chairman
- Executive Appointments: InMode Ltd. announced the appointment of Moshik Itzkovich as Chief Financial Officer, succeeding Yair Malca who stepped down earlier this month; Itzkovich, previously the Senior Vice President of Finance, is expected to enhance the company's financial strategy with his extensive experience.
- Board Leadership Change: Shlomo Nass has been appointed as Chairman, succeeding Michael Anghel who retired earlier this month, and Nass's leadership is anticipated to provide new strategic direction and strengthen the board's governance capabilities.
- Market Reaction: Following the announcement, InMode's shares rose 0.07% in pre-market trading on Nasdaq, reaching $13.98 per share, indicating market confidence in the new executive team.
- Company Outlook: This executive transition reflects InMode's commitment to improving financial management and corporate governance, which may positively impact future business development and competitive positioning in the market.
See More
InMode Appoints New Chairman and CFO
- Board Leadership Change: InMode has appointed Dr. Shlomo Nass as the new Chairman of the Board, succeeding Dr. Michael Anghel, who retired earlier this month; Nass will leverage his extensive experience in corporate governance and financial oversight to drive the company's long-term strategic growth.
- Financial Leadership Transition: Moshik Itzkovich has been appointed as Chief Financial Officer, replacing Yair Malca, who stepped down earlier this month; Itzkovich's years in senior finance roles at InMode ensure continuity and stability in financial management.
- Support for Strategic Goals: CEO Moshe Mizrahy emphasized that Nass's expertise will be crucial for executing strategic priorities and enhancing shareholder value, indicating the company's commitment to governance and financial transparency.
- Transition Period Assurance: Yair Malca will serve as a consultant until the company's Annual General Meeting to ensure a smooth transition for the new CFO, reflecting the company's emphasis on leadership stability.
See More
InMode Appoints New Chairman and CFO to Drive Strategic Growth
- Board Appointment: InMode Ltd. has appointed Dr. Shlomo Nass as Chairman of the Board, succeeding the recently retired Dr. Michael Anghel, with Nass expected to leverage his extensive experience in corporate governance and financial oversight to support the company's long-term strategic growth.
- CFO Transition: Concurrently, Moshik Itzkovich has been appointed as Chief Financial Officer, replacing Yair Malca, with Itzkovich's long tenure in senior finance roles at InMode ensuring continuity and stability in financial management.
- Strategic Support: CEO Moshe Mizrahy emphasized that Nass's expertise will be crucial for executing strategic priorities and enhancing shareholder value, reflecting the company's commitment to future growth.
- Transition Assurance: Yair Malca will serve as a consultant until the company's Annual General Meeting to ensure a smooth transition for the new CFO, demonstrating the company's focus on leadership changes and commitment to future financial stability.
See More
InMode Participates in Multiple Investor Conferences
- Investor Conference Schedule: InMode will participate in the Barclays Virtual West Coast Bus Tour on May 20, featuring outgoing CFO Yair Malca and Senior VP of Finance Moshik Itzkovich, aimed at enhancing investor engagement.
- Healthcare Industry Conference: On June 3, InMode will also attend the Jefferies Global Healthcare Conference for an in-person fireside chat, further showcasing its innovative capabilities in medical technology and increasing its visibility among investors.
- Technology Innovation Showcase: InMode focuses on developing and manufacturing medical devices utilizing novel radiofrequency technology across various fields, including plastic surgery and gynecology, aiming to drive industry advancement through emerging surgical procedures and improved existing treatments.
- Forward-Looking Statements: The company notes in its press release that future financial or operational performance may be influenced by various uncertainties, and actual results could differ materially from expectations, urging investors to exercise caution regarding these forward-looking statements.
See More
InMode Announces Participation in Investor Conferences
- Investor Conference Schedule: InMode Ltd. will participate in the Barclays Virtual West Coast Bus Tour on May 20, 2026, featuring outgoing CFO Yair Malca and Senior VP of Finance Moshik Itzkovich, showcasing the company's innovations in medical technology.
- Face-to-Face Engagement: At the Jefferies Global Healthcare Conference on June 3, InMode will hold an in-person fireside chat at 12:45 PM ET in New York, providing one-on-one meetings with analysts to bolster investor confidence in the company's future prospects.
- Technological Innovation Background: InMode is a leading global provider of medical technologies focused on developing and manufacturing devices that utilize novel radiofrequency technology, committed to advancing emerging surgical procedures and improving existing treatments, highlighting its technical prowess in the healthcare sector.
- Forward-Looking Statement Reminder: The company notes that all forward-looking statements are based on management's current expectations and assumptions, with actual outcomes potentially differing significantly due to uncertainties and risks, urging investors to approach these statements with caution.
See More
InMode Reports Q1 2026 Financial Results with Mixed Performance
- Revenue Growth: InMode's Q1 2026 GAAP revenues reached $82 million, reflecting a 5% year-over-year increase, indicating the company's ability to maintain stable growth even in a challenging macroeconomic environment, which enhances market confidence.
- Margin Decline: Despite the revenue increase, GAAP gross margin fell from 78% in 2025 to 75% in Q1 2026, primarily due to rising costs, which could impact future profitability and investor sentiment.
- Shareholder Returns: As of March 31, 2026, InMode repurchased 2.55 million ordinary shares, returning $34.8 million to shareholders, demonstrating a proactive approach to capital allocation that helps enhance shareholder value.
- Executive Changes: CFO Yair Malca has stepped down and will serve as a consultant, while Board Chair Dr. Michael Anghel has resigned, indicating potential shifts in the company's strategic direction and market response.
See More
